Fate Therapeutics (FATE) Granted Foundational U.S. Patent Covering iPSC-derived CAR T Cells
Tweet Send to a Friend
Fate Therapeutics, Inc. (NASDAQ: FATE) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,370,452 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
